A Phase 2 Study of Weekly Albumin-Bound Paclitaxel (Abraxane(®)) Given as a Two-Hour Infusion

PURPOSE: Paclitaxel is an effective therapy for patients with solid tumors. While the albumin-bound formulation eliminates the hypersensitivity reaction caused by the Cremaphor solvent, significant peripheral neuropathy persists when given over the standard 30-minute infusion time. We sought to dete...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Paik, Paul K., James, Leonard P., Riely, Gregory J., Azzoli, Christopher G., Miller, Vincent A., Ng, Kenneth K., Sima, Camelia S., Heelan, Robert T., Kris, Mark G., Moore, Erin, Rizvi, Naiyer A.
格式: Artigo
語言:Inglês
出版: 2011
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3581346/
https://ncbi.nlm.nih.gov/pubmed/21461889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-011-1621-0
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍